DK0657170T3 - Produkter til anvendelse af høje initialdoser af cetrorelix og fremstilling af en kombinationspakning til anvendelse ved te - Google Patents

Produkter til anvendelse af høje initialdoser af cetrorelix og fremstilling af en kombinationspakning til anvendelse ved te

Info

Publication number: DK0657170T3
Authority: DK; Denmark
Prior art keywords: cetrorelix; tea; products; preparation; high initial
Prior art date: 1993-12-09

Application number

DK94118466T

Other languages

English (en)

Inventor

Juergen Prof Engel

Thomas Dr Reissmann

Peter Dr Hilgard

Original Assignee

Asta Medica Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-12-09

Filing date

1994-11-24

Publication date

2000-07-31

1994-11-24 Application filed by Asta Medica Ag filed Critical Asta Medica Ag

2000-07-31 Application granted granted Critical

2000-07-31 Publication of DK0657170T3 publication Critical patent/DK0657170T3/da

Links

108700008462 cetrorelix Proteins 0.000 title abstract 4
229960003230 cetrorelix Drugs 0.000 title abstract 2
241001122767 Theaceae Species 0.000 title 1
SBNPWPIBESPSIF-MHWMIDJBSA-N cetrorelix Chemical compound C([C@@H](C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@H](C)C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC=1C=NC=CC=1)NC(=O)[C@@H](CC=1C=CC(Cl)=CC=1)NC(=O)[C@@H](CC=1C=C2C=CC=CC2=CC=1)NC(C)=O)C1=CC=C(O)C=C1 SBNPWPIBESPSIF-MHWMIDJBSA-N 0.000 title 1
KFEFLCOCAHJBEA-ANRVCLKPSA-N cetrorelix acetate Chemical compound CC(O)=O.C([C@@H](C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@H](C)C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC=1C=NC=CC=1)NC(=O)[C@@H](CC=1C=CC(Cl)=CC=1)NC(=O)[C@@H](CC=1C=C2C=CC=CC2=CC=1)NC(C)=O)C1=CC=C(O)C=C1 KFEFLCOCAHJBEA-ANRVCLKPSA-N 0.000 abstract 3
229960001865 cetrorelix acetate Drugs 0.000 abstract 2
UCANQOXFIYWYIX-IDEADWEOSA-N (2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(carbamoylamino)pentanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N-[(2R)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide 4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid Chemical compound OC(=O)c1cc2ccccc2c(Cc2c(O)c(cc3ccccc23)C(O)=O)c1O.CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O.CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O UCANQOXFIYWYIX-IDEADWEOSA-N 0.000 abstract 1
239000013066 combination product Substances 0.000 abstract 1
229940127555 combination product Drugs 0.000 abstract 1
238000012423 maintenance Methods 0.000 abstract 1
230000003211 malignant effect Effects 0.000 abstract 1
239000000047 product Substances 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Reproductive Health (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Tea And Coffee (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK94118466T 1993-12-09 1994-11-24 Produkter til anvendelse af høje initialdoser af cetrorelix og fremstilling af en kombinationspakning til anvendelse ved te DK0657170T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4342091A DE4342091A1 (de)	1993-12-09	1993-12-09	Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten

Publications (1)

Publication Number	Publication Date
DK0657170T3 true DK0657170T3 (da)	2000-07-31

Family

ID=6504624

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94118466T DK0657170T3 (da)	1993-12-09	1994-11-24	Produkter til anvendelse af høje initialdoser af cetrorelix og fremstilling af en kombinationspakning til anvendelse ved te

Country Status (10)

Country	Link
US (1)	US5663145A (da)
EP (1)	EP0657170B1 (da)
JP (1)	JP3439855B2 (da)
AT (1)	ATE190495T1 (da)
CA (1)	CA2137595C (da)
DE (2)	DE4342091A1 (da)
DK (1)	DK0657170T3 (da)
ES (1)	ES2145803T3 (da)
GR (1)	GR3033319T3 (da)
PT (1)	PT657170E (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6828415B2 (en) *	1993-02-19	2004-12-07	Zentaris Gmbh	Oligopeptide lyophilisate, their preparation and use
EP0788799A3 (en)	1996-02-07	1998-10-21	ASTA Medica Aktiengesellschaft	LHRH-Antagonists in the treatment of fertility disorders
DE19644994A1 (de) *	1996-10-30	1998-05-07	Asta Medica Ag	Diagnostisches Mittel
US7005418B1 (en) *	1999-09-23	2006-02-28	Zentaris Gmbh	Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
DE10024451A1 (de)	2000-05-18	2001-11-29	Asta Medica Ag	Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
DE10137174A1 (de) *	2001-07-31	2003-02-13	Zentaris Ag	Verwendung von LHRH-Antagonisten in nichtkastrierenden Dosen zur Verbesserung der T-Zellen-vermittelten Immunität
US20040138138A1 (en) *	2001-08-02	2004-07-15	Jurgen Engel	Use of LHRH-antagonists in doses that do not cause castration for the improvement of T-cell mediated immunity
ME00509B (me) *	2002-09-27	2011-10-10	Zentaris Gmbh	Oblik za terapijsku primjenu aktivnih peptida sa dugotrajnim oslobođenjem aktivnog sastojka i postupak za njihovo dobijanje
US20040224000A1 (en) *	2003-05-05	2004-11-11	Romano Deghenghi	Implants for non-radioactive brachytherapy of hormonal-insensitive cancers
EP1674082A1 (de) *	2004-12-22	2006-06-28	Zentaris GmbH	Verfahren zur Herstellung von sterilen Suspensionen oder Lyophilisaten schwerlöslicher basischer Peptidkomplexe, diese enthaltende pharmazeutische Formulierungen sowie ihre Verwendung als Arzneimittel
EP1891964A1 (en) *	2006-08-08	2008-02-27	AEterna Zentaris GmbH	Application of initial doses of LHRH analogues and maintenance doses of LHRH antagonists for the treatment of hormone-dependent cancers and corresponding pharmaceutical kits
EP2095818A1 (en) *	2008-02-29	2009-09-02	AEterna Zentaris GmbH	Use of LHRH antagonists at non-castrating doses
RU2013128357A (ru) *	2010-12-06	2015-01-20	Астрон Рисёрч Лимитед	Стабильный готовый к применению инъекционный раствор цетрореликса

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT81285B (de)	1914-07-30	1920-09-10	I Gio Ansaldo & C S A I Gio Ah	Verfahren zur thermischen Vorbehandlung von Stahl.Verfahren zur thermischen Vorbehandlung von Stahl.
GB1204580A (en) *	1968-10-05	1970-09-09	Aspro Nicholas Ltd	Pharmaceutical dosage forms
US3733407A (en) *	1971-08-25	1973-05-15	Syntex Corp	Menopause treatment
US3969502A (en) *	1972-04-14	1976-07-13	Schering Aktiengesellschaft	Method for contraception by the administration of sequential contraceptive preparations
DE2335265A1 (de) *	1973-07-09	1975-01-30	Schering Ag	Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten
IE45770B1 (en) *	1976-10-06	1982-11-17	Wyeth John & Brother Ltd	Pharmaceutical dosage forms
DE2729068A1 (de) *	1977-06-28	1979-01-11	Rainer Dr Med Liedtke	Verfahren zur freisetzungssteuerung von arzneimitteln aus kapseln
CA1097233A (en) *	1977-07-20	1981-03-10	George K. E. Gregory	Packages
FR2403078A1 (fr) *	1977-09-19	1979-04-13	Lafon Labor	Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
EP0002495B1 (de) *	1977-12-14	1984-02-15	Asta-Werke Aktiengesellschaft Chemische Fabrik	Erzeugnisse zur Anwendung in der cytostatischen Therapie
JPS5548064A (en) *	1978-03-03	1980-04-05	Yamanouchi Pharma Co Ltd	Pressureereducing sealing vessel into which agent in protein is sealed
DE2834226A1 (de) *	1978-08-04	1980-02-28	Merck Patent Gmbh	Presskoerper und verfahren sowie vorrichtung zu ihrer herstellung
JPS57166164A (en) *	1981-04-03	1982-10-13	Fujisawa Pharmaceutical Co	Case for enclosing ampoule
US4415085A (en) *	1981-12-21	1983-11-15	Eli Lilly And Company	Dry pharmaceutical system
DK90883A (da) *	1982-03-18	1983-09-19	Merck & Co Inc	Beholder til osmotisk afgivelse af et stof eller en stofblanding
US4564363A (en) *	1983-07-13	1986-01-14	Smithkline Beckman Corporation	Delayed action assembly
US4569927A (en) *	1984-02-23	1986-02-11	The Salk Institute For Biological Studies	GnRH Antagonists IV
US5064813A (en) *	1984-08-02	1991-11-12	Fernand Labrie	Combination therapy for selected sex steroid dependent cancers
GB8518828D0 (en) *	1985-07-25	1985-08-29	American Home Prod	Tablet package
US4817819A (en) *	1985-12-19	1989-04-04	Berlex Laboratories, Inc.	Container for tablets
US4662880A (en) *	1986-03-14	1987-05-05	Alza Corporation	Pseudoephedrine, brompheniramine therapy
EP0268066A3 (en) *	1986-10-17	1990-07-11	Syntex (U.S.A.) Inc.	Fertility control and uterine therapy in dogs with luteinizing hormone releasing hormone antagonists
JPS63162619A (ja) *	1986-12-25	1988-07-06	Teisan Seiyaku Kk	遅溶性顆粒及びそれを用いた持続性複合顆粒
KR910002669B1 (ko) *	1986-12-25	1991-05-03	데이산세이야꾸 가부시끼가이샤	서방성 과립 및 그를 함유하는 지속성 복합과립
US5116818A (en) *	1987-03-10	1992-05-26	Medical College Of Hampton Roads	Method and kit for contraception with GnRH-antagonist
US5028430A (en) *	1987-05-08	1991-07-02	Syntex (U.S.A.) Inc.	Delivery systems for the controlled administration of LHRH analogs
GB2206046B (en) *	1987-06-25	1991-04-03	Alza Corp	Multi-unit delivery system
US4800191A (en) *	1987-07-17	1989-01-24	Schally Andrew Victor	LHRH antagonists
IL88083A (en) *	1987-11-06	1992-11-15	Tanabe Seiyaku Co	Controlled release pharmaceutical dosage form and its preparation
JPH07552B2 (ja) *	1987-11-06	1995-01-11	田辺製薬株式会社	持効性製剤
SU1554911A1 (ru) *	1988-05-17	1990-04-07	Ленинградское Научно-Производственное Объединение Технологического Оборудования Для Производства Готовых Лекарственных Средств "Прогресс"	Пенал дл гранулированных лекарств
US5036047A (en) *	1988-09-29	1991-07-30	Pitman-Moore, Inc.	Method and composition for preventing conception
US5171835A (en) *	1988-10-21	1992-12-15	The Administrators Of The Tulane Educational Fund	LHRH antagonists
ATE90203T1 (de) *	1989-03-17	1993-06-15	Pitman Moore Inc	Kontrollierte, verzoegerte wirkstofffreisetzung von makromolekularen proteinen.
JP2653255B2 (ja) *	1990-02-13	1997-09-17	武田薬品工業株式会社	長期徐放型マイクロカプセル
US5046618A (en) *	1990-11-19	1991-09-10	R. P. Scherer Corporation	Child-resistant blister pack
EP0569096A1 (en) *	1992-05-08	1993-11-10	Akzo Nobel N.V.	Depot preparation
TW333456B (en) *	1992-12-07	1998-06-11	Takeda Pharm Ind Co Ltd	A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.

1993
- 1993-12-09 DE DE4342091A patent/DE4342091A1/de not_active Ceased
1994
- 1994-11-24 DE DE59409205T patent/DE59409205D1/de not_active Expired - Lifetime
- 1994-11-24 EP EP94118466A patent/EP0657170B1/de not_active Expired - Lifetime
- 1994-11-24 AT AT94118466T patent/ATE190495T1/de active
- 1994-11-24 DK DK94118466T patent/DK0657170T3/da active
- 1994-11-24 ES ES94118466T patent/ES2145803T3/es not_active Expired - Lifetime
- 1994-11-24 PT PT94118466T patent/PT657170E/pt unknown
- 1994-12-08 CA CA002137595A patent/CA2137595C/en not_active Expired - Lifetime
- 1994-12-08 US US08/354,838 patent/US5663145A/en not_active Expired - Lifetime
- 1994-12-09 JP JP30647594A patent/JP3439855B2/ja not_active Expired - Lifetime
2000
- 2000-04-26 GR GR20000401003T patent/GR3033319T3/el unknown

Also Published As

Publication number	Publication date
CA2137595C (en)	2005-05-31
ATE190495T1 (de)	2000-04-15
PT657170E (pt)	2000-07-31
GR3033319T3 (en)	2000-09-29
DE4342091A1 (de)	1995-06-14
DE59409205D1 (de)	2000-04-20
JPH07194670A (ja)	1995-08-01
US5663145A (en)	1997-09-02
ES2145803T3 (es)	2000-07-16
EP0657170A1 (de)	1995-06-14
CA2137595A1 (en)	1995-06-10
JP3439855B2 (ja)	2003-08-25
EP0657170B1 (de)	2000-03-15

Publication	Publication Date	Title
NO914751L (no)	1992-06-04	N,o-sulfaterte heparosaner, fremgangsmaate ved fremstilling av dem og farmasoeytiske blandinger inneholdende dem
ES2156840T1 (es)	2001-08-01	Medicamento que contiene polisulfato de pentosano e implante para tratar la fibrosis.
WO1994027589A3 (en)	1995-01-26	Antidepressant dosage form
AP9801392A0 (en)	1998-12-31	Concentrated antibody preparation.
UA26213C2 (uk)	1999-07-19	Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
ES2061799T3 (es)	1994-12-16	Nuevo preparado medicamentoso y procedimiento para su preparacion.
ES2094923T3 (es)	1997-02-01	Procedimiento de preparacion de medicamentos conservados que contienen proteinas humanas, para fines de infusion o inyeccion.
LU90935I2 (en)	2002-09-05	Azopt-brinzolamide
ES2191034T3 (es)	2003-09-01	Formulaciones de liberacion controlada para la liberacion de metoprolol durante 24 horas.
ES2186674T3 (es)	2003-05-16	Comprimidos de liberacion sostenida que contienen niacina y estuches.
NO871602D0 (no)	1987-04-15	1-hydroksy-2-pyridoner, fremgangsmaate til deres fremstilling og legemidler som inneholder dem samt ved fremstillingen av 1-hydroksy-2-pyridoner dannede mellomprodukter.
GR3033319T3 (en)	2000-09-29	Products for the application of high initial doses of cetrorelix and preparation of a combined package for use in treating diseases.
GR3006089T3 (da)	1993-06-21
IL106521A0 (en)	1993-11-15	Pharmaceutical composition for the treatment or prevention of elevated intraocular pressure
DE59811768D1 (de)	2004-09-09	Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine
NO891759D0 (no)	1989-04-27	Fremgangsmaate ved bleking av bomullsplagg og avslitbare pellets for bruk ved fremgangsmaaten.
MY129782A (en)	2007-04-30	Novel medical use
GB9525598D0 (en)	1996-02-14	Pharmaceutical tablet formulations
WO1999018941A3 (en)	2000-01-13	Ih-MODULATORS
ZA877901B (en)	1989-06-28	Active compounds for use in the treatment of tumors
FR2691615B1 (fr)	1994-11-18	Procédé de préparation culinaire, de conditionnement, de distribution et de traitement culinaire ultérieur de plats cuisinés.
EP0342416A3 (en)	1990-06-13	Medicine
DE3579074D1 (de)	1990-09-13	Verminderung der toxischen wirkungen von anthrachinon-medikamenten.
IL96161A0 (en)	1991-07-18	Application of n-methyl-2-(3-pyridyl)tetrahydrothiopyran-2-carbothioamide 1-oxide to the preparation of medicinal products intended for the treatment of coronary insufficiency
HUT59012A (en)	1992-04-28	Production, as medicinal product, of "inhaletta" - an inclusion complex tablet based on beta-cyclodextrin, for inhalation purposes